Israel Englander’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
14,404
-9,602
-40% -$142K ﹤0.01% 5065
2026
Q1
$348K Buy
+24,006
New +$298K ﹤0.01% 4942
2025
Q4
Sell
-14,944
Closed -$113K 6014
2025
Q3
$113K Buy
+14,944
New +$115K ﹤0.01% 5677
2025
Q2
Sell
-16,698
Closed -$209K 5861
2025
Q1
$209K Buy
16,698
+6,764
+68% +$130K ﹤0.01% 5290
2024
Q4
$304K Buy
9,934
+1,667
+20% +$49K ﹤0.01% 5060
2024
Q3
$294K Buy
+8,267
New +$284K ﹤0.01% 5202
2024
Q2
Sell
-5,038
Closed -$144K 5886
2024
Q1
$144K Buy
5,038
+472
+10% +$16.2K ﹤0.01% 5480
2023
Q4
$168K Buy
4,566
+2,886
+172% +$90.6K ﹤0.01% 5228
2023
Q3
$55.4K Buy
+1,680
New +$46.6K ﹤0.01% 5456
2023
Q1
Sell
-5,389
Closed -$248K 6365
2022
Q4
$248K Sell
5,389
-513
-9% -$13.9K ﹤0.01% 5207
2022
Q3
$150K Buy
5,902
+36
+0.6% +$1.39K ﹤0.01% 5803
2022
Q2
$192K Sell
5,866
-1,238
-17% -$40.2K ﹤0.01% 5661
2022
Q1
$240K Buy
7,104
+4,509
+174% +$295K ﹤0.01% 5728
2021
Q4
$275K Buy
+2,595
New +$339K ﹤0.01% 5631
2021
Q2
Sell
-10,045
Closed -$4.08M 6527
2021
Q1
$4.08M Sell
10,045
-4,036
-29% -$1.8M ﹤0.01% 2801
2020
Q4
$5.68M Buy
+14,081
New +$4.38M ﹤0.01% 2316

Other funds holding BDSX

Israel Englander's BDSX Position: Q2 2026 in Review

Israel Englander reduced its Biodesix (BDSX) stake by 40% in Q2 2026, selling an estimated $142K and leaving 14,404 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #5065.

Israel Englander first reported a position in BDSX in Q4 2020 and has held it in 16 quarters since. The position peaked at $5.68M in Q4 2020. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Israel Englander held 14,404 shares of Biodesix worth $325K as of Q2 2026.
  • Israel Englander sold 9,602 Biodesix shares in Q2 2026, an estimated $142K.
  • Biodesix made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5065 holding.
  • Israel Englander first reported a position in Biodesix in Q4 2020 and has held it in 16 quarters since.
  • Israel Englander's Biodesix position peaked at $5.68M in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.